Pliant Therapeutics (PLRX) Times Interest Earned (2019 - 2026)
Pliant Therapeutics (PLRX) posted quarterly Times Interest Earned of -$0.58 for Q1 2026, up 99.21% year-over-year from -$0.29 in Q1 2025, and up 92.22% quarter-over-quarter from -$7.51 in Q4 2025.
Pliant Therapeutics (PLRX) Times Interest Earned (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Times Interest Earned for 8 consecutive years, with -$0.58 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 99.21% year-over-year to -$0.58; the TTM figure through Mar 2026 stood at -$3.2 (up 94.94% YoY), while the FY2025 annual figure was -$0.68, up 40.79% from the prior year.
- Times Interest Earned improved to -$0.58 in Q1 2026 per PLRX's latest filing, from -$7.51 in the prior quarter.
- Across five years, Times Interest Earned topped out at $34.0 in Q4 2022 and bottomed at -$150.43 in Q3 2023.
- Historically, Times Interest Earned has averaged -$73.89 across 5 years, with a median of -$70.71 in 2024.
- Annual changes were most pronounced in 2023 — Times Interest Earned sank 530.98% — and 2026, when it soared 99.21%.
- Pliant Therapeutics' Times Interest Earned stood at $34.0 in 2022, then tumbled by 530.98% to -$146.53 in 2023, then jumped by 69.01% to -$45.42 in 2024, then soared by 83.46% to -$7.51 in 2025, then jumped by 92.22% to -$0.58 in 2026.
- Business Quant data shows PLRX's Times Interest Earned at -$0.58 in Q1 2026, -$7.51 in Q4 2025, and -$34.69 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Pliant Therapeutics | 71.52 Mn | 71.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.58 |
| Dec 31, 2025 | -7.51 |
| Sep 30, 2025 | -34.69 |
| Jun 30, 2025 | -1.12 |
| Mar 31, 2025 | -73.67 |
| Dec 31, 2024 | -45.42 |
| Sep 30, 2024 | -70.71 |
| Jun 30, 2024 | -69.86 |
| Mar 31, 2024 | -104.57 |
| Dec 31, 2023 | -146.53 |
| Sep 30, 2023 | -150.43 |
| Jun 30, 2023 | -148.36 |
| Mar 31, 2023 | -135.35 |
| Dec 31, 2022 | 34.00 |
| Sep 30, 2022 | -106.14 |
| Jun 30, 2022 | -148.21 |
| Mar 31, 2022 | -47.02 |
| Dec 31, 2021 | 18.92 |
| Sep 30, 2021 | -271.13 |
| Jun 30, 2021 | -114.52 |